newsfilter
← Latest News
GlobeNewswire·

Kineta to Present at the 5th Annual Macrophage-Directed Therapies Summit

KA

SEATTLE, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (NASDAQ:KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance,